11,552
Total Claims
$1.2M
Drug Cost
668
Beneficiaries
$1,811
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-94%
Opioid rate vs peers
0.2% vs 2.6% avg
+70%
Cost per patient vs peers
$1,811 vs $1,068 avg
+20%
Brand preference vs peers
10.8% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
18
Opioid Claims
$162
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 1,242 claims · $901K
Generic: 10,249 claims · $307K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 187 | $290K |
| Apixaban | 81 | $139K |
| Semaglutide | 24 | $49K |
| Empagliflozin | 26 | $44K |
| Linagliptin | 23 | $38K |
| Cyclosporine | 36 | $25K |
| Fluticasone Propionate | 79 | $24K |
| Atorvastatin Calcium | 875 | $24K |
| Amlodipine Besylate | 981 | $21K |
| Losartan Potassium | 752 | $21K |
| Budesonide/Formoterol Fumarate | 33 | $21K |
| Ipratropium/Albuterol Sulfate | 19 | $18K |
| Mirabegron | 12 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $16K |
| Insulin Aspart | 13 | $14K |
Prescribing Profile
Patient Profile
75
Avg Age
52%
Female
0.92
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data